Clinical Trials Directory

Trials / Completed

CompletedNCT01791400

Effect of Metoclopramide Versus Sumatriptan for Emergency Department Treatment of Migraine Headache

Study of Effects of Metoclopramide Versus Sumatriptan on Migraine Headache

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
124 (actual)
Sponsor
Isfahan University of Medical Sciences · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine which drug makes lower migraine headache

Detailed description

There are different options to manage benign headache in emergency department.The investigators compared Intravenous metoclopramide with Subcutaneous sumatriptan to relieve pain in emergency department.

Conditions

Interventions

TypeNameDescription
DRUGmetoclopramide, injection,20mg, one timemetoclopramide, intravenous injection,20mg, one time
DRUGSumatriptan, injection, 6 mg, one timeSumatriptan, subcutaneous injection, 6 mg, one time

Timeline

Start date
2009-07-01
Primary completion
2010-11-01
Completion
2010-11-01
First posted
2013-02-15
Last updated
2013-02-15

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT01791400. Inclusion in this directory is not an endorsement.

Effect of Metoclopramide Versus Sumatriptan for Emergency Department Treatment of Migraine Headache (NCT01791400) · Clinical Trials Directory